You are here

Lexington Biosciences Inc.

Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
LNB
CSE Index: 
Currency: 

Lexington Biosciences, Inc. is a development stage medical device company operating within the healthcare industry. Lexington is focused on development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The current focus of the company is to develop and market the HeartSentry endothelial function measurement product.

You are here

Lexington Biosciences Inc. (LNB)

SEDAR Information

Company Info

Address
1055 West Hastings Street
Suite 1900
Vancouver, BC V6E 2E9
Canada
Phone
(800) 320-2640
Email
info@lexingtonbiosciences.com
Listing date
Tuesday, May 9, 2017
Transfer Agent
AST Trust Company (Canada)

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
3,785,340
Reserved for Issuance: 
322,740

Bulletins

01/05/2020

2020-0502 - Delist - Lexington Biosciences Inc. (LNB)

le 1 mai/May 2020

At the request of the company the common shares of Lexington Biosciences Inc.  will be delisted at market close on May 4, 2020.

For further information please see the issuer’s press release.

________________________

À la demande de la société, les actions ordinaires de Lexington Biosciences Inc.  seront radiées de la cote à la fermeture des marchés le 4 mai 2020.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2020-08-11_TechTues_MedicalDevices_Website

Tech Tuesdays

Tuesday, August 11, 2020 -
4:15pm to 5:00pm
08-12_Virtual_Industry_Updates_Whats_Next_for_the_Cannabis_Industry_Imagery_Website

Virtual Industry Updates: What's Next for the Cannabis Industry?

Wednesday, August 12, 2020 -
3:00pm to 4:15pm